Dermatology & Medspa M&A

Last updated

In short

What is a dermatology practice or medspa worth?

In Axia Growth's analysis of closed small-business sales, dermatology practices and medspas are grouped in the Healthcare sector, where businesses with under $500K of SDE sold for a median 3.4x SDE (middle half 2.7x-4.2x) across 182 sales, updated October 28, 2026. According to American Med Spa Association (AmSpa), there were 10,488 U.S. medical spa locations in 2023, and only 3% were owned by private equity firms.

Dermatology is one of the most private-equity-penetrated physician specialties, with over 35 PE-backed platforms and an estimated 10% to 15% of private practices PE-backed. Advisers now expect a 'consolidation of consolidators.' Medspas are the opposite: 10,488 locations in 2023, 81% single-location, and only 3% owned by private equity firms. Public multiple data specific to either is thin, so buyers lean on platform comparables and disclosed deal terms.

Why published multiples differ

Published multiples differ mostly because they use different earnings and deal sizes. Small, owner-run businesses (under $2M of earnings) are priced on SDE, seller's discretionary earnings, which adds back the owner's pay, so SDE multiples are lower. From $2M of earnings up, buyers price on EBITDA, and multiples rise with size. Averages that mix sizes, or quote larger private-equity deals, read higher than a small-business sale.

Multiples by deal size

Sector: Healthcare. Median and middle half (p25-p75) of sale price to earnings.

Closed small-business sales in the Healthcare sector, by deal size. Axia Growth analysis of closed small-business sales, updated October 28, 2026.
Size bandnMedian multiplep25-p75Basis
Under $500K SDE1823.4x2.7x-4.2xSDE
$500K-$1M SDE423.4x2.5x-4.4xSDE
$1M-$2M SDE223.3x2.7x-7.5xSDE
$2M-$3M EBITDA135.1x3.1x-10.9xEBITDA
$5M-$10M EBITDA148.8x3.4x-10.7xEBITDA
$10M+ EBITDA1712.9x9.4x-18.5xEBITDA

Source: Axia Growth analysis of 4,554 closed small-business sales over $500K, aggregated and de-identified. Data as of 2026-10-28. Methodology.

No published cell for the Healthcare size band: $3M-$5M EBITDA. Each has fewer than 10 closed sales, so Axia Growth does not estimate a multiple for it.

Selling a medspa to a private equity firm

Private equity buys medspas through platforms that add locations. Expect them to check provider licensing and supervision, membership and repeat-client revenue, and whether injectors stay after the sale. Price follows size: in Axia Growth's Healthcare sector data, businesses with under $500K of SDE sold for a median 3.4x SDE across 182 closed sales.

Source: Axia Growth analysis of 4,554 closed small-business sales over $500K, aggregated and de-identified. Data as of October 28, 2026.

Dermatology practice EBITDA multiples by size

Smaller dermatology practices and medspas are priced on SDE, larger ones on EBITDA. Median sale multiples in Axia Growth's Healthcare sector data: Under $500K SDE, 3.4x (182 sales); $500K-$1M SDE, 3.4x (42 sales); $1M-$2M SDE, 3.3x (22 sales); and $10M+ EBITDA, 12.9x (17 sales). Every published size band is in the table on this page.

Source: Axia Growth analysis of 4,554 closed small-business sales over $500K, aggregated and de-identified. Data as of October 28, 2026.

  • 10,488[6]

    U.S. medical spa locations, 2023

    Up from 8,899 in 2022, per AmSpa's 2024 State of the Industry report

  • $1,398,833[6]

    Average annual medspa revenue, 2023

    Up from $1,307,587 in the prior report

  • 3%[6]

    Share of medspas owned by private equity firms

    Unchanged from AmSpa's 2022 report; 81% of medspas are single-location

  • 35+[1]

    PE-backed dermatology platforms

    Across nearly 20 states, per a Physician Growth Partners white paper cited by Healio

  • 134[3]

    PE dermatology practice transactions, 2020-2022

    VMG Health; 171 in 2017-2019; excludes medspas

M&A activity snapshot

Dermatology was one of the first physician specialties to consolidate under private equity, and it remains among the most penetrated. A 2019 study found PE penetration was highest in dermatology, with 7.5% of dermatologists working in a PE-acquired practice. A 2023 study estimated 10% to 15% of all private dermatology practices are backed by PE firms.

Deal flow peaked before COVID and has since moderated. An earlier study counted 17 PE groups acquiring 184 practices over six years, about 381 clinics overall, with about 36% of acquired practices in Texas and Florida. VMG Health reports 134 PE dermatology transactions in 2020-2022, versus 171 in 2017-2019.

Medspas are a separate, far less consolidated market. AmSpa counted 10,488 medical spas in 2023, up from 8,899 in 2022. 81% of medical spas are single-location, and only 3% are owned by private equity firms.

Who is buying

Dermatology buyers are mostly PE-backed management groups, now numbering in the dozens. A Physician Growth Partners white paper counts over 35 PE-backed dermatology platforms throughout nearly 20 states. Forefront Dermatology had over 200 dermatology clinics across 22 states when Partners Group agreed to acquire it from OMERS Private Equity.

The current phase is platforms combining. QualDerm Partners and Pinnacle Dermatology merged in 2022, supporting 158 practices in 17 states. Schweiger Dermatology acquired United Skin Specialists' 10 office locations in January 2024, then filed to acquire CSI Medical Group, which offers services at 48 locations across 15 California counties.

Medspa buyers include dermatology platforms adding cash-pay services. Advisers interviewed by Healio expect PE-backed dermatology groups to acquire smaller practices to integrate cosmetic dermatology, plastic surgery and medspas. Multi-site medspa operators are a second pool: multi-location medical spas have nine locations on average, up from six.

What buyers look for

For dermatology, buyers underwrite the payer mix and the provider model. In other markets, about a quarter of Schweiger patient revenue is from government payors. Physician capacity is scarce, and VMG notes the scarcity of board-certified dermatologists may pose hiring and retention challenges. Supervision records also get diligence, since virtually all states require that physician assistants only provide services within the scope of care of a supervising physician.

For medspas, buyers look at repeat business and ticket size. AmSpa reports an average of 73% of medical spa patients are repeat patients, an average of 245 patient visits per month, and an average spend of $527 per visit.

Ownership and medical-direction structure is the main legal diligence item. 67% of single-owner practices are owned by non-MDs/surgeons, and 74% of medical directors come from non-core specialties. Each of those facts has to be squared with the target state's corporate-practice rules.

What raises the multiple

A dermatology practice or medspa that draws platform interest typically shows:

  • For dermatology, multiple board-certified dermatologists with a documented supervision model for physician assistants and nurse practitioners.
  • A medical-dermatology base with cosmetic services layered on, rather than cosmetic revenue alone.
  • For medspas, repeat-patient share at or above the 73% industry average and revenue above the $1,398,833 average.
  • An ownership structure that already complies with state corporate-practice and fee-splitting law, so the buyer does not have to restructure at close.
  • A stable medical director. 48% of medical spas hired a medical director in the past year, so continuity in that role stands out.
  • Clean records on regulated services such as elective IV therapy, now subject to added rules in some states.

Valuation and deal structure

Public multiple data specific to dermatology or medspas is thin. Most platform deals do not disclose EBITDA, and public deal datasets do not break out either vertical. Smaller private deals generally price below larger private-equity deals, so a single-location medspa should not expect a platform multiple.

Disclosed deal terms show how platform deals are paid. In Schweiger's California filing, consideration consists of $60,000,000 in cash plus preferred and common units valued at $51,500,000. Part of the price was paid in equity of the buyer's holding company.

Ownership structures follow corporate-practice law. Under California's rules, if a medspa is a professional corporation, 51% must be owned by licensed physicians. AmSpa warns that hiring a physician medical director for a non-physician-owned medspa is illegal in Illinois. In the Schweiger filing, SDG Mgmt, a management services organization, provides non-clinical administrative services to dermatology practices in eight states.

State transaction review adds time. California's OHCA requires notice when the proposed fair market value of the transaction is $25 million or more. In the Schweiger filing, OHCA set a date by which it could waive or require a cost and market impact review.

Outlook

Expect dermatology consolidation to continue mainly as platform-to-platform deals over the next 12-24 months. Advisers expect PE investors nearing fund-end to drive the consolidation of consolidators, eventually condensing to 10 or 15 active dermatology consolidators. Independent practices will face fewer, larger bidders.

Medspa regulation is tightening state by state. Texas HB 3749 limits elective IV therapy outside medical settings: administration can be delegated only to a physician assistant, advanced practice registered nurse or registered nurse under adequate supervision. Indiana will require medical spas to register with the medical board beginning January 1, 2027, with nearly identical bills in Iowa, Florida, Arizona and Colorado.

Growth in the underlying market supports demand. AmSpa describes a medical aesthetics industry that has eclipsed $17 billion and is growing by more than $1 billion per year. Medspas with documented compliance and repeat patients should be best placed for platform buyers.


Own a dermatology practice or medspa and want a sense of what it could be worth before you talk to anyone? Run the valuation tool or see the broader healthcare services M&A picture. See also: how independent sponsors build deal flow in fragmented niches.

Other Healthcare Services subindustries

Frequently asked questions

What is a dermatology practice or medspa worth?

In Axia Growth's analysis of closed small-business sales, dermatology practices and medspas are grouped in the Healthcare sector, where businesses with under $500K of SDE sold for a median 3.4x SDE (middle half 2.7x-4.2x) across 182 sales, updated October 28, 2026. According to American Med Spa Association (AmSpa), there were 10,488 U.S. medical spa locations in 2023, and only 3% were owned by private equity firms.

What multiple do dermatology practices and medspas sell for?

Axia Growth groups dermatology practices and medspas in the Healthcare sector, the closest published proxy: businesses with under $500K of SDE sold for a median 3.4x SDE across 182 sales (Axia Growth analysis of closed small-business sales, updated October 28, 2026).

SDE or EBITDA: which applies to my dermatology practice or medspa?

Axia Growth reports multiples of SDE (seller's discretionary earnings) for businesses with under $2M of earnings, where owner-operated businesses are usually priced, and multiples of EBITDA from $2M up, matching how buyers and brokers talk about deal size. For the Healthcare sector, Axia Growth publishes both SDE and EBITDA bands.

Who buys dermatology practices?

PE-backed management groups. Named platforms include Forefront Dermatology, with over 200 clinics across 22 states when Partners Group agreed to acquire it, and Schweiger Dermatology, which agreed to acquire California Skin Institute's 48-location practice. Sources: Partners Group; California Department of Health Care Access and Information, Office of Health Care Affordability.

Do state transaction-review laws affect dermatology deals?

Yes, in some states. Schweiger's California deal was filed with the state's Office of Health Care Affordability because the proposed fair market value of the transaction is $25 million or more. Its disclosed consideration included $60,000,000 in cash. Source: California Department of Health Care Access and Information, Office of Health Care Affordability.

How do I get a value range for my business?

Enter your industry and annual earnings in the free business value calculator for a value range drawn from the same closed-sales data. The multiples by sector page shows every published size band.

Sources

  1. Private equity in dermatology: Consolidation, modernization are on the horizon — Healio, 2025-04-16 (accessed 2026-10-03)
  2. Private equity gobbles up dermatology practices, raising questions about outcomes, costs — Healthcare Dive, 2019-07-24 (accessed 2026-10-03)
  3. Private Equity and the Dermatology Industry — VMG Health (Brad Witt, CPA), 2023-06-29 (accessed 2026-10-03)
  4. Partners Group, in partnership with existing physician owners, acquires Forefront Dermatology — Partners Group, 2022-02-10 (accessed 2026-10-03)
  5. Material Change Transaction Notice: CSI Medical Group (MCN 2024-11-12-1249) — California Department of Health Care Access and Information, Office of Health Care Affordability, 2024-11 (accessed 2026-10-03)
  6. 2024 Medical Spa State of the Industry Executive Report Recap — American Med Spa Association (AmSpa), 2024 (accessed 2026-10-03)
  7. Med Spa Ownership — American Med Spa Association (AmSpa), 2026 (accessed 2026-10-03)
  8. Texas IV Therapy Bill HB 3749 Signed into Law by Governor Abbott — American Med Spa Association (AmSpa), 2025-06 (accessed 2026-10-03)
  9. Indiana SB 282 Has Passed: What Med Spas Need to Know — American Med Spa Association (AmSpa), 2026-03 (accessed 2026-10-03)
  10. Medical Spa State of the Industry Report — American Med Spa Association (AmSpa), 2026 (accessed 2026-10-03)

Cite this guide

In Axia Growth's analysis of closed small-business sales, dermatology practices and medspas are grouped in the Healthcare sector, where businesses with under $500K of SDE sold for a median 3.4x SDE (middle half 2.7x-4.2x) across 182 sales, updated October 28, 2026. According to American Med Spa Association (AmSpa), there were 10,488 U.S. medical spa locations in 2023, and only 3% were owned by private equity firms. Dermatology and medspa M&A in 2026: 10,488 U.S. medspas with only 3% PE-owned, 35+ PE-backed dermatology platforms, and state rules reshaping deal structure.

When using information from this guide, cite Axia Growth and link to this page.

Axia Growth. Dermatology & Medspa M&A. Updated 2026-10-30. https://axiagrowth.com/resources/industries/healthcare/dermatology-medspa

For buyers

Have a mandate in Dermatology & Medspa? Share your buy box.

Share your buy box

For owners

Own a business in Dermatology & Medspa? Book a confidential call.

Book a confidential call

For buyers

See who's in your buy box.

Submit your criteria

For owners

Thinking about selling?

Tell us about your business